Transarterial Chemoembolization (TACE) as A Palliative Treatment Option for Liver Metastases from Non-Small Cell Lung Cancer (NSCLC)
International Journal of Radiology and Imaging Technology · 2016
DOI: 10.23937/2572-3235.1510019 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiology and Imaging Technology, 2016. Verfasst von Tatjana Gruber-Rouh. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The study aimed at evaluating the local tumor control, survival data and prognostic factors following treatment with transarterial chemoembolization (TACE) in the palliative therapy of patients with liver metastases from non-small-lung-cancer (NSCLC).
Zitieren
APA
Gruber-Rouh, T. (2016). Transarterial Chemoembolization (TACE) as A Palliative Treatment Option for Liver Metastases from Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiology and Imaging Technology. https://doi.org/10.23937/2572-3235.1510019
Vancouver
Gruber-Rouh T. Transarterial Chemoembolization (TACE) as A Palliative Treatment Option for Liver Metastases from Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiology and Imaging Technology. 2016. doi:10.23937/2572-3235.1510019
BibTeX
@article{GruberRouh2016,
author = {Gruber-Rouh, Tatjana},
title = {Transarterial Chemoembolization (TACE) as A Palliative Treatment Option for Liver Metastases from Non-Small Cell Lung Cancer (NSCLC)},
journal = {International Journal of Radiology and Imaging Technology},
year = {2016},
doi = {10.23937/2572-3235.1510019}
}
EUVIMED